Add Company
Join Now

Genagon Theraputics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Genagon Theraputics's estimated annual revenue is currently $2.4M per year.(i)
  • Genagon Theraputics's estimated revenue per employee is $201,000

Employee Data

  • Genagon Theraputics has 12 Employees.(i)
  • Genagon Theraputics grew their employee count by -20% last year.

Genagon Theraputics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$17.1M85-21%N/AN/A
#2
$99.7M49622%N/AN/A
#3
$22.9M114-67%N/AN/A
#4
$27.3M1367%N/AN/A
#5
$20.9M10428%N/AN/A
#6
$103.1M5134%N/AN/A
#7
$9.4M472%N/AN/A
#8
$2.4M12-20%N/AN/A
#9
$28.1M14027%N/AN/A
#10
$5M254%N/AN/A
Add Company

What Is Genagon Theraputics?

Genagon Therapeutics drug development is based on ground-breaking discoveries of unstudied proteins and their life cycles in innate immune cells. Genagon was founded in 2015 and is growing a strong and broad patent portfolio with opportunities for internal development and future partnerships. The company is supported financially by among others, Beijer Ventures and Almi Invest.

keywords:N/A

N/A

Total Funding

12

Number of Employees

$2.4M

Revenue (est)

-20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Genagon Theraputics News

2022-03-22 - Notice of Annual General Meeting 2022 in Enzymatica AB (publ)

Guest Researcher at the Department of Immunology , Pittsburgh University, USA . Other current assignments: CEO, Genagon Therapeutics AB .

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.8M12-29%N/A
#2
$2.2M12N/AN/A
#3
$2.1M120%N/A
#4
$1.5M12-25%N/A
#5
$1.9M129%N/A